Eversense E3 CGM System

Eversense E3 CGM System


The Eversense E3 is an implantable continuous glucose monitor (CGM) sensor indicated for use in adults that provides continuous interstitial glucose monitoring via a pill sized subcutaneous sensor with a life of up to 6 months. The rechargeable, water resistant, removable transmitter sits on top of the skin and wirelessly sends data to compatible smart devices. The transmitter also and provides vibrating on body alerts when glucose hits customizable preset high or low level, even when smart device is not in range. Predictive alerts help users know if glucose is trending high or low. No finger-stick confirmation required when making treatment decisions. Eversense is the only CGM sensor approved for use during an MRI though the transmitter must be temporarily removed. Using the Eversense Now app, up to five caregivers can view real-time glucose readings and receive alerts on compatible smart devices.


  • Alerts and Alarms
  • No Finger-Stick Confirmation
  • Long Transmitter Range
  • Transmits Data Continuously
  • Sends Data to Smart Device
  • Shares Data Via App


Transmitter & Sensor Size:
1.5 x 1.7 x 0.6 in. (Transmitter); 0.1 x 0.7 in. (Sensor)
Transmitter & Sensor Weight:
0.39 oz. (Transmitter only)
Calibration Details:
Calibrate every 12 hours. Blood glucose levels must be between 40 and 400 mg/dl to calibrate.
Sensor Duration:
Up to 180 days
Transmitter Range:
The transmitter must be within 25 feet of your mobile device.
Warm-Up Time:
24 hours
Battery Type:
Rechargeable lithium polymer battery
Data-Management Software:
Works with Eversense DMS, a web-based data-management application that automatically uploads glucose readings from the Eversense app. Compatible with Glooko data-management system.
Approved Ages: